Chinese researchers investigate the benefits of using biodegradable polymers for scaffolds, outlined in ‘Fabrication and characterization of porous polycaprolactone scaffold via extrusion-based cryogenic 3D printing for tissue engineering.’ Explaining that there have historically been limitations due to issues like affordability, lack of efficiency in fabrication, and inferior process control, the authors of the study endeavor to improve on previous attempts to use 3D porous PCL scaffolds through combining extrusion-based cryogenic 3D printing with freeze-drying approaches.
Tissue engineering (TE) is a broad field today and one that is expansive with research and many different goals—most of which end in the ultimate discovery of a way to create sustainable bioprinted organs for transplantation. In creating or regenerating tissue, scientists usually work with scaffolds, living cells, and other ‘bioactive factors.’ Structures like scaffolds must be biocompatible, and obviously non-toxic too if they are being implanted into a human patient. Polycaprolactone (PCL) is a commonly used polymer in creating scaffolds, suitable due to features like:
- Biodegradability
- Biocompatibility
- Low melting point
- Good strength
- Good solubility
The researchers explain that extrusion-based cryogenic 3D printing (ECP) is gaining more popularity as a choice for bioprinting because it allows for greater strength in scaffolds, whether they are made of collagen, chitosan, PLGA, or other materials. In this study, the authors used ECP to fabricate PCL scaffolds and then study the results.
To ensure success in printing, the researchers relied on several different treatments, to include using a rough-surfaced glass slide as a collector, adding a transitional path at the corners of the adhesive area, and scrubbing slides with ethanol, to begin with. Porosity was measured, with results showing an increase due to ‘widening of filament offset.’
In terms of measuring biocompatibility, the researchers found that while cell attachment was ‘not well promoted’ at first, cell proliferation was ‘effectively facilitated’ because of the rough surface and porosity of scaffolds.
“Although more stretched cells were found on the surface of EMP group after 7 days, the number of cells on ECP scaffolds were much higher and their morphologies become more stretched as compared to the ones at day 3,” concluded the researchers. “Thus, it can be concluded that PCL scaffolds fabricated via ECP are highly biocompatible and better support cell adhesion and proliferation as compared to EMP scaffolds.
“Overall, the fabricated PCL scaffold, with such improved structural, physico-chemical, and biological features, can be a promising candidate for tissue engineering applications.”
Tissue engineering takes many forms today, from heart tissue engineering to bone tissue engineering to tailored skin grafts. What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.
[Source / Images: ‘Fabrication and characterization of porous polycaprolactone scaffold via extrusion-based cryogenic 3D printing for tissue engineering’]Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
You May Also Like
Further Understanding of 3D Printing Design at ADDITIV Design World
ADDITIV is back once again! This time, the virtual platform for additive manufacturing will be holding the first-ever edition of ADDITIV Design World on May 23rd from 9:00 AM –...
3D Printer Maker EVO-tech Reborn as NEVO3D — Once More With Feeling
EVO-tech was a 3D printing service and original equipment manufacturer established in 2013 and based in Schörfling am Attersee, Austria. The company produced high-quality material extrusion systems featuring linear bearings,...
3D Systems Brings 3D Printed PEEK Cranial Implant to the U.S. with FDA Clearance
For more than 10 years, 3D Systems (NYSE:DDD) has worked hand-in-hand with surgeons to plan over 150,000 patient-specific cases, and develop more than two million instruments and implants from its...
CDFAM Returns to Berlin for Second Annual Symposium
The second CDFAM Computational Design Symposium is scheduled for May 7-8, 2024, in Berlin, and will convene leading experts in computational design across all scales. Building upon the first event...